Hyperpigmentation Patients Report Low Satisfaction and Limited Awareness of Treatment Options A new cross-sectional survey reveals that hyperpigmentation, especially among patients with deeper skin tones, continues to be a significantly…
Read More
Curated by the JDD Editors Missed any of our July highlights? As the official partner of the Skin of Color Update , July is our “Bridging the Gap in Dermatology”…
Read More
Biologics for Mastocytosis? New Evidence Supports Targeted Treatment Success Could the next breakthrough for mastocytosis already be in your therapeutic toolbox? A new article in the July issue of JDD…
Read More
July Is Hyperpigmentation & Melasma Awareness Month – Did You Know We Have a Curated Resource Just for You? As summer sun peaks, so does your patients' concern about dark…
Read More
JDD Article Highlights Triple-combination therapies for acne are known for their efficacy, but the complexity of multiple treatments often reduces patient adherence. Enter CAB gel (Clindamycin phosphate 1.2%/adapalene 0.15%/benzoyl peroxide…
Read More
Top the Leaderboard: Sharpen Your Diagnostic Eye with the Inclusive Derm Atlas Test Your Skills with The Full Spectrum of Dermatology: Take the Quiz! Think you have mastered dermatology across…
Read More
Cleansing is a significant daily hygiene step used by many to fight against infections and keep the skin healthy. However, cleansing also presents new challenges in the face of skin…
Read More
JDD Video Exclusive At the recent Revolutionizing Atopic Dermatitis (RAD) conference, Dr. Linda Stein Gold, Director of Dermatology Clinical Research and Division Head of Dermatology at Henry Ford Health,…
Read More
By Allison Sit Semaglutide – a glucagon-like peptide (GLP)-1RA – improved outcomes for obese patients with hidradenitis suppurativa (HS), according to a study presented at EADV Congress 2024. The study…
Read More
By Allison Sit A National Eczema Association (NEA) study published in JAMA Dermatology identified patient-reported attributes associated with a “flare” of atopic dermatitis. The study sought to develop a clearer…
Read More
by Allison Sit Healio wrote about two JDD studies on psoriasis treatments including one on the benefits of long-term ixekizumab. The study, “Benefits Over Five Years of Ixekizumab Treatment in…
Read More
by Allison Sit Managed Healthcare Executive and Healio both wrote about a JDD study on the underrepresentation of racial and ethnic minority groups in vitiligo research. The study, “Racial and…
Read More
